CMPS - Compass Pathways Plc
5.73
-0.150 -2.618%
Share volume: 2,642,057
Last Updated: 03-19-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$5.88
-0.15
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-01-2024 | 10-31-2024 | 02-27-2025 | 05-08-2025 | 07-31-2025 | 11-04-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 38.573 M | 43.322 M | 47.896 M | 48.414 M | 49.616 M | 42.933 M | 40.536 M | |
| Selling general and admin | 13.672 M | 14.253 M | 14.968 M | 16.273 M | 18.736 M | 12.608 M | 13.211 M | |
| Research and development | 24.901 M | 29.069 M | 32.928 M | 32.141 M | 30.880 M | 30.325 M | 27.325 M | |
| Total expenses | 38.573 M | 43.322 M | 47.896 M | 48.414 M | 49.616 M | 42.933 M | 40.536 M | |
| 12.31% | 10.56% | 1.08% | 2.48% | -13.47% | -5.58% | |||
| Operating income | -38.573 M | -43.322 M | -47.896 M | -48.414 M | -49.616 M | -42.933 M | -40.536 M | |
| Ebit | -33.867 M | -39.221 M | -39.169 M | -45.060 M | -18.772 M | -39.013 M | -138.430 M | |
| Pretax income | -34.965 M | -37.925 M | -38.329 M | -42.309 M | -17.510 M | -38.266 M | -137.947 M | |
| 8.47% | 1.07% | 10.38% | -58.61% | 118.54% | 260.49% | |||
| Income tax | 222.000 K | 176.000 K | 173.000 K | 1.023 M | 354.000 K | 137.000 K | -230.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -35.187 M | -38.101 M | -38.502 M | -43.332 M | -17.864 M | -38.403 M | -137.717 M | |
| -8.28% | -1.05% | -12.54% | 58.77% | -114.97% | -258.61% |